Consistently, small nucleolar RNA host gene 3 (SNHG3) overexpression enhance the EMT and sorafenib resistance of HCC cells through promoting CD151 expression (Zhang, Wang, Wu, Wu, Huang, Liu et al., 2019). The gene discussed is SNHG3; the disease is hepatocellular carcinoma.